These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation. Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750 [TBL] [Abstract][Full Text] [Related]
31. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6. Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713 [TBL] [Abstract][Full Text] [Related]
32. Decreased Jagged1 expression in vascular smooth muscle cells delays endothelial regeneration in arteriovenous graft. Guo Q; Huang F; Qing Y; Feng S; Xiao X; Wang Y; Liang M; Wang T; Mitch WE; Cheng J Cardiovasc Res; 2020 Nov; 116(13):2142-2155. PubMed ID: 31913453 [TBL] [Abstract][Full Text] [Related]
33. S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo. Wu YJ; Sala-Newby GB; Shu KT; Yeh HI; Nakayama KI; Nakayama K; Newby AC; Bond M J Vasc Surg; 2009 Nov; 50(5):1135-42. PubMed ID: 19878790 [TBL] [Abstract][Full Text] [Related]
34. IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury. Kohno T; Urao N; Ashino T; Sudhahar V; Inomata H; Yamaoka-Tojo M; McKinney RD; Fukai T; Ushio-Fukai M Am J Physiol Cell Physiol; 2013 Sep; 305(6):C591-600. PubMed ID: 23657573 [TBL] [Abstract][Full Text] [Related]
35. Cross talk between vascular smooth muscle cells and monocytes through interleukin-1β/interleukin-18 signaling promotes vein graft thickening. Li P; Li YL; Li ZY; Wu YN; Zhang CC; A X; Wang CX; Shi HT; Hui MZ; Xie B; Ahmed M; Du J Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2001-11. PubMed ID: 25012128 [TBL] [Abstract][Full Text] [Related]
36. Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis. Tucka J; Yu H; Gray K; Figg N; Maguire J; Lam B; Bennett M; Littlewood T Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2421-8. PubMed ID: 25234814 [TBL] [Abstract][Full Text] [Related]
38. MIA SH3 Domain ER Export Factor 3 Deficiency Prevents Neointimal Formation by Restoring BAT-Like PVAT and Decreasing VSMC Proliferation and Migration. Lei Y; Xu J; Li M; Meng T; Chen M; Yang Y; Li H; Zhuang T; Zuo J Front Endocrinol (Lausanne); 2021; 12():748216. PubMed ID: 34858331 [TBL] [Abstract][Full Text] [Related]
39. Leukotriene-C4 synthase, a critical enzyme in the activation of store-independent Orai1/Orai3 channels, is required for neointimal hyperplasia. Zhang W; Zhang X; González-Cobos JC; Stolwijk JA; Matrougui K; Trebak M J Biol Chem; 2015 Feb; 290(8):5015-5027. PubMed ID: 25540197 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation. Wang YS; Wang HY; Liao YC; Tsai PC; Chen KC; Cheng HY; Lin RT; Juo SH Cardiovasc Res; 2012 Sep; 95(4):517-26. PubMed ID: 22802111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]